PLX PHARMA INC.

Profile

Company Names

PLX PHARMA INC.
DIPEXIUM PHARMACEUTICALS, LLC

Addresses

9 FISHERS LANE, SUITE E, SPARTA, NJ 07871

8285 EL RIO STREET, SUITE 130, HOUSTON, TX 77054

270 BENEDICT ROAD, STATEN ISLAND, NY 10304

22 CAMELOT COURT, WHITE PLAINS, NY 10603

Phone Numbers

(973) 409-6541
(713) 842-1249
917-533-1469
914-949-3898

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$66,127,968.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2020-11-18 
$18,008,599.00 
$18,008,599.00 
$0.00 
Equity 
7
2020-05-15 
$8,000,000.00 
$8,000,000.00 
$0.00 
Equity 
6
2019-02-20 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
5
2017-06-14 
$18,191,869.00 
$18,191,869.00 
$0.00 
 
4
2013-07-12 
$2,750,000.00 
$5,500,000.00 
$2,750,000.00 
Equity 
3
2013-02-13 
$930,000.00 
$1,750,000.00 
$820,000.00 
Equity 
2
2012-03-30 
$507,500.00 
$2,500,000.00 
$1,992,500.00 
Equity 
1
2010-07-23 
$2,740,000.00 
$3,000,000.00 
$260,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
 
BALKEMA 
DIRECTOR
PLX PHARMA INC.   |  PLX PHARMA INC.
ANTHONY 
 
BARTSH 
DIRECTOR
PLX PHARMA INC.
KIRK 
 
CALHOUN 
DIRECTOR
PLX PHARMA INC.   |  NEUROSIGMA, INC.   |  PLX PHARMA INC.   |  NANTHEALTH, INC.   |  AFAXYS, INC.
ROBERT 
 
CASALE 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  MASSACHUSETTS MUTUAL VARIABLE LIFE SEPARATE ACCOUNT III   |  MASSACHUSETTS MUTUAL LIFE INSURANCE CO   |  MASSACHUSETTS MUTUAL VARIABLE ANNUITY SEPARATE ACCOUNT V   |  FIRST AID BEVERAGES, INC.   |  PLX PHARMA INC.   |  ALITAIR PHARMACEUTICALS, INC.
CHRISTOPHER 
 
COUGHLIN 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
JACK 
 
DEAN 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
EFTHYMIOS 
 
DELIARGYRIS 
EXECUTIVE OFFICER
PLX PHARMA INC.
ROBERT 
J. 
DELUCCIA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DIPEXIUM PHARMACEUTICALS, LLC   |  ACURX PHARMACEUTICALS, LLC   |  ACURX PHARMACEUTICALS, INC.
MICHAEL 
 
DUFFY 
DIRECTOR
STRATEGIC GLOBAL BALANCED TRUST   |  FOUNDRY FUND LLC   |  STRATEGIC FUNDS SPC   |  STRATEGIC GLOBAL BALANCED INSTITUTIONAL TRUST I   |  STRATEGIC PRIVATE EQUITY FUND III LP   |  STRATEGIC INSTITUTIONAL FUNDS SPC   |  STRATEGIC PORTFOLIOS (RESTRICTED) LTD SPC   |  STRATEGIC HIGH YIELD TRUST   |  STRATEGIC US EQUITY TRUST   |  STRATEGIC INTERNATIONAL EQUITY TRUST   |  SIM HEDGED STRATEGIES TRUST   |  HSP INTERNATIONAL, INC.   |  STRATEGIC PRIVATE EQUITY FUND IV, L.P.   |  DIPEXIUM PHARMACEUTICALS, LLC   |  CYLENT SYSTEMS, INC.   |  STRATEGIC NON-CORE EMERGING MARKETS EQUITY TRUST   |  BARKLY PROTECTS, INC.   |  CITYBASE. INC.   |  CITYBASE, INC.   |  KANSAS CITY SOCIAL INVESTMENT POOL, LLC   |  ACURX PHARMACEUTICALS, LLC   |  THORNTON RISING, LLC   |  CHICAGO MODEL 1, LLC   |  NEWBOLD HOLDINGS GROUP, LLC
NATASHA 
 
GIORDANO 
EXECUTIVE OFFICER, DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  CLEARPOINT LEARNING SYSTEMS, INC.   |  HEALTHCARE CORP OF AMERICA   |  PLX PHARMA INC.   |  PLX PHARMA INC.   |  MATINAS BIOPHARMA HOLDINGS, INC.
JOHN 
 
HADDEN 
DIRECTOR
PLX PHARMA INC.
JOHN 
W. 
HADDEN II 
DIRECTOR
IRX THERAPEUTICS, INC.   |  PLX PHARMA INC.
STEVEN 
 
HURD 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
STEVEN 
D. 
HURD 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
DAVID 
 
JORDEN 
EXECUTIVE OFFICER
PLX PHARMA INC   |  PLX PHARMA INC.   |  CYTOMEDIX INC   |  NANOSPECTRA BIOSCIENCES INC   |  PLX PHARMA INC.   |  NUO THERAPEUTICS, INC.
MILOS 
 
KOTEREC 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
JOHN 
 
LEONE 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC   |  PINEBRIDGE NEW EUROPE PARTNERS II-A, L.P.   |  WINDTREE THERAPEUTICS INC /DE/   |  JEWEL HOLDINGS LP
DAVID 
 
LUCI 
DIRECTOR
PLX PHARMA INC.   |  ACURX PHARMACEUTICALS, LLC   |  AMERI HOLDINGS, INC.   |  DIGITAL PRIME TECHNOLOGIES, INC.
DAVID 
P. 
LUCI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DIPEXIUM PHARMACEUTICALS, LLC   |  ACURX PHARMACEUTICALS, LLC   |  DLCC, LLC   |  DIGITAL PRIME TECHNOLOGIES, LLC   |  KRYPTOS + KIDDIES, LLC   |  ACURX PHARMACEUTICALS, INC.
WILLIAM 
J. 
MCSHERRY, JR. 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
GARY 
 
MOSSMAN 
EXECUTIVE OFFICER
PLX PHARMA INC.   |  GLYCOS BIOTECHNOLOGIES INC   |  PLX PHARMA INC.
RITA 
 
O-CONNOR 
EXECUTIVE OFFICER
PLX PHARMA INC.   |  ULAB SYSTEMS, INC.
JOHN 
 
TERRANA 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC   |  ACURX PHARMACEUTICALS, LLC
MICHAEL 
J. 
VALENTINO 
EXECUTIVE OFFICER, DIRECTOR
TRIA BEAUTY, INC.   |  BREAKTHROUGH PRODUCTS, INC.   |  PLX PHARMA INC.
ELLEN 
 
ZAROFF 
DIRECTOR
DIPEXIUM PHARMACEUTICALS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-11-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-11-18 
2020-05-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-15 
2019-03-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-02-20 
2017-06-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2017-06-14 
2013-07-22
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2013-07-12 
2013-02-25
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2013-02-13 
2012-04-23
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-03-30 
2011-11-07
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-07-23 
2010-07-30
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RAYMOND JAMES + ASSOCIATES, INC.
705
NONE
NONE
RAYMOND JAMES + ASSOCIATES, INC.
705
NONE
NONE
JMP SECURITIES LLC
22208
NONE
NONE
RAYMOND JAMES + ASSOCIATES, INC.
705
NONE
NONE
JANNEY MONTGOMERY SCOTT LLC
463